The Use of LiDCOplus in Fluid Resuscitation Decision-Making

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Shock
Interventions
DEVICE

LiDCOplus haemodynamic monitor

Patients in study group receive intravenous fluid bolus as part of standard fluid resuscitation. Fluid responsiveness (i.e. improvement in cardiac output) is estimated using both standard clinical parameters and by LiDCOplus haemodynamic monitor (with the clinician initially blinded to the latter) before a final decision about fluid responsiveness is made.

Trial Locations (1)

G4 0SF

Glasgow Royal Infirmary, Glasgow

All Listed Sponsors
lead

NHS Greater Glasgow and Clyde

OTHER

NCT03349749 - The Use of LiDCOplus in Fluid Resuscitation Decision-Making | Biotech Hunter | Biotech Hunter